Semaglutide Reduces CV Events in High-Risk Patients with Type 2 Diabetes Mellitus
- Mark H. Ebell
Scholary Output:
Contribution to journal
Article
Peer-reviewSustainable Development Goals
- SDG 3 Good Health and Well
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Peer-reviewOriginal language
English (US)Journal (Volume, Issue Number)
American family physician (Volume 95, Issue 6)Publication milestones
- Published - 03/15/2017
Publication status
Published - 03/15/2017
ISSN
0002-838XPublication IDs
- Scopus: 85056257283
- PubMed: 28318215
Access to documents
Publication metrics
Metrics
SciVal
Author count
1
SciVal
Paper percentile
25
Fractional count
1
Fractional count
1
Fractional count
1
Fractional count
1
PlumX
Captures
46
Citation count
1
